Which Skin Is GOURI Suited To — the Director of Miso Clinic Explains
“Is GOURI right for my skin?” is the question we are asked most often in consultation. Answered honestly from the data, “no study has broken this down by skin type” is the accurate answer. The human data on liquid-form polycaprolactone comes to 33 people in total — not a size at which subgroup analysis is possible. A judgement can still be made; it is just that the criteria come from the mechanism and the examination rather than from data. This article sets out those criteria as they are.
The short answer
If you answer “which skin is GOURI (liquid-form polycaprolactone) suited to?” from the data, the accurate answer is “no study has broken this down by skin type.” The published human data comes to 33 people in total, which is not a size at which subgroup analysis is possible. So sentences such as “good for oily skin” or “particularly suited to dry skin” have no trial behind them. A judgement can still be made, and the criteria come from the mechanism and the examination rather than from data. GOURI is not a treatment that fills what has hollowed but one that sends a signal to the dermis, so it is not an answer to change caused by lost volume, and it is pointed in the right direction for change caused by skin itself thinning and its texture breaking down. Reduced to one line: if the face has hollowed, GOURI is not it; if the skin has thinned, GOURI is a candidate. And that distinction is made by examination, not by photographs.
Two kinds of ageing have to be told apart first
What we hear most often in the consulting room is “I don’t think I’ve lost weight, but my face isn’t what it used to be.” The changes that come with age fall broadly into two strands, and this is exactly where the treatment needed diverges.
| Aspect | Ageing as lost volume | Ageing as thinning skin |
|---|---|---|
| What has decreased | Fat and bone | Collagen in the dermis |
| What is visible | Hollowing at the nasolabial folds, anterior cheek and temples; sagging | Fine lines settling in, pores lengthening, dullness because light is not reflected evenly |
| Treatment pointed the right way | Fillers, lifting procedures | Collagen boosters — GOURI belongs here |
| Does GOURI address it | No | It becomes a candidate |
In practice the two more often arrive together. When they do, deciding what to do first and what to leave until later bears on the result more than choosing the type of treatment does. Which comes first, booster or lifting, is set out in booster first or lifting first.
Skin that GOURI is pointed toward
Below are the cases in which we put GOURI forward as a candidate in practice. We state plainly that these are judgements that follow from the mechanism, not indication criteria verified by trial.
- Volume has not greatly hollowed, but the feeling is that the skin has thinned and lost firmness
- Fine lines that have settled in independently of expression are the concern
- Texture has coarsened and light reflects unevenly, so the whole face looks dull
- Fatigue has set in with the unnaturalness of treatments that fill
- A wish to address thin areas such as around the eyes and mouth as well — but please read the caveat below
- A wish to firm up the underlying skin alongside laser or radiofrequency lifting
The caveat about the eye area, neck and back of the hands
The manufacturer’s official FAQ states of GOURI that “we recommend using it on the face only, and we are collecting clinical data on other indications such as hand and neck injections.” The published human studies also covered the face alone, and for the neck, décolletage and back of the hands we could not find a single published study or trial registration number. The manufacturer’s treatment guidance does list 2 points for the eye area on its own, but that is guidance on how to inject, not a statement that efficacy and safety have been confirmed in the eye area. How far the data goes by region is set out in GOURI somewhere other than the face.
When GOURI is not the answer
This side matters more. The reason for not recommending a treatment is often not that it is dangerous but that it is pointed the wrong way, so money and time are spent and the wanted change does not come.
| If this is the situation | Why |
|---|---|
| Lost volume is the main concern | GOURI is an aqueous solution and is not a product designed to fill volume immediately |
| The wish is to tighten sagging skin | Dermal density and sagging are different problems. Tightening is the job of the lifting class |
| A visible change is needed within a month | The earliest change recorded in the literature is at 4 weeks |
| The plan is to judge after a single session | Session planning is itself an area where the manufacturer’s guidance and the figures in circulation disagree |
| Pigmentation or redness is the main concern | GOURI is not a treatment aimed at pigment or vessels |
There are also situations in which we do not recommend the treatment at all — pregnancy or breastfeeding, active infection or inflammation at the site, a history of hypersensitivity to the components, and layering into a site that already contains irreversible material (PCL, PLLA, CaHA). That said, much of the contraindication list in wide circulation consists of sentences repeated without attribution on distributor and clinic pages, and the manufacturer’s official FAQ contains no contraindication list at all. We went through those sources one by one in before you have GOURI — what is different because of this particular product.
If the skin is thin and dry — what changes is safety, not efficacy
We are often asked whether GOURI works better on thin skin. There is almost no treatment research that stratifies by skin thickness as an independent variable. Where confirmed data does exist, it is on safety rather than efficacy — there are case reports of nodules, irregularity and burns occurring more frequently in thin skin.
So what we actually change in thin skin is not an expectation that “this treatment will work better,” but the plane and the volume injected. The thinner the skin, the more room there is for a superficial placement to show through as irregularity, and the same volume spreads differently. The criteria are set out in anti-ageing treatments for people with thin, dry skin.
What can be expected, and what must not be
| What can be expected | Thickness of the evidence |
|---|---|
| Change in the direction of increased dermal thickness and density | Significant at six weeks in a rat photoaging model (p < 0.001). There is no human tissue data |
| Change assessed as improvement in skin quality and volume | 30-person human pilot, to six months (Ponzo M et al., PRS Global Open 2025;13(11), PMID 41210393) |
| Change documented photographically at 4 weeks | 2-person case series, mean GAIS 3.5 |
| What must not be expected | Why |
|---|---|
| A change immediately after treatment | What is raised straight afterwards is the water injected plus oedema from the injection |
| Hollowed volume being filled | The formulation is an aqueous solution and the product was not designed to fill volume |
| Lasting more than a year | The longest time point observed in humans is six months, and beyond that it has never been measured |
| Dissolving it if you are unhappy | Polycaprolactone does not dissolve with hyaluronidase |
| A “side-effect-free treatment” | Every injectable treatment carries the possibility of swelling, bruising, redness and nodules |
The “6–12 months” that circulates widely for duration is how long the material takes to break down, not how long the effect lasts. How the two get conflated in citation is written out in GOURI — from the day of injection to months later.
What fills the space where the data is missing
Reading this far leaves one question — how can we recommend it when the data is only 33 people? The honest answer is this. What stands in for judgement in an area where data is thin is not conviction but procedure.
- We distinguish in consultation between what there is data for and what there is not.
- For regions and indications without data, we put the alternatives that do have data alongside them first.
- Because the material is irreversible, we defer where deferring is possible.
What we actually look at and ask in consultation at Miso Clinic in Daegu is written out as it is in if you are having a GOURI consultation in Daegu.
Frequently asked questions
How do I know whether GOURI suits my skin type?
This is not a treatment that divides by skin type (oily, dry, combination). What divides it is whether the main problem is lost volume or thinned skin, and that distinction is made by examination. If both are present, a consultation to decide the order is needed.
Am I too young for it?
No age cut-off exists in the data. Nor is the age distribution of 33 published human subjects a size from which an indication age could be stated. We look at the state of the dermis and the goal rather than at age.
Does it work on acne scars or pores?
We could not find published data evaluating liquid-form polycaprolactone with scars or pores as the primary target. Change in the direction of shadows softening as dermal density rises is explicable from the mechanism, but it has not been verified as a scar treatment.
I have sensitive skin — is it all right?
No study exists that examines risk by underlying condition for liquid-form polycaprolactone — with 33 human subjects, subgroup analysis is not possible at all. So the accurate answer is neither “it is dangerous” nor “it is fine” but “there is no data,” and the judgement is made from examination and history.
What if I have both lost volume and thinned skin?
In practice this is the more common case. Deciding what to do first and what to leave until later bears on the result more than choosing the type of treatment does. The order depends on the goal, on downtime, and on whether to put the reversible treatments first.
Can men have it?
We could not find a study of liquid-form polycaprolactone broken down by sex. It is generally known that male skin is thicker and produces more sebum, but there is no data measuring a difference in outcome by sex for this product. Treatment in men generally is set out in lifting for men.
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- Ponzo M et al., PRS Global Open 2025;13(11), PMID 41210393 — 30-person pilot, six-month follow-up.
- Rat photoaging model study — significant increase in dermal thickness and type I collagen at six weeks after treatment (p < 0.001, p = 0.003), 40 rats.
- Case series (2 people, 3 months, 10 points on the face, 31G needle, mean GAIS 3.5) and case report (1 person).
- GOURI manufacturer official FAQ — guidance on treatment area, original text: “We recommend to use GOURI on the face only. We are collecting clinical data about other indications, such as hand, neck injections.”
- Case data on adverse events in thin skin — reports of nodules, irregularity and burns occurring more frequently. There is almost no treatment research stratifying by skin thickness as an independent variable.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English · 日本語 · 简体中文 · Español · Tiếng Việt · ภาษาไทย · Bahasa Indonesia